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A R T I C L E
Gender diff erences in psychotropic 
medicine dispensing at a pharmacy in 
Melbourne, Australia, 1954 and 1961
Michael Leach and Rebecca Kippen
Abstract
An examination of psychotropic dispensing by gender 
in historic prescription books could help trace the ori-
gins of psychopharmacology in Australia. Th is study 
examined gender diff erences in psychotropic medicine 
dispensing at a Melbourne pharmacy during the 1950s 
and 1960s. Data were sourced from two prescription 
books. Numbers of prescriptions dispensed in 1954 and 
1961 were calculated for each gender and adjusted for 
population size. More prescriptions were dispensed for 
females than for males, by factors of 2 and 1.7 to 1 in 
1954 and 1961, respectively. Th is diff erential persisted 
across prescription type (barbiturate psychotropic, non-
barbiturate psychotropic, and non-psychotropic). Psy-
chotropic dispensing shifted from barbiturates (77% in 
1954; 38% in 1961) to newer, safer non-barbiturates 
(23% in 1954; 62% in 1961), irrespective of gender.
Introduction
Prior to the 1950s, there were few eff ective, safe, and 
humane options for the management of mental health 
disorders. People with mental health disorders were 
managed to a small extent in the community and to a 
large extent in purpose-built asylums, through methods 
such as electroconvulsive therapy and physical restraint 
or through any of a small number of psychotropic 
drugs.1,2 Drugs in the barbiturate class were among the 
most commonly used prescription psychotropic medi-
cines in the fi rst half of the twentieth century.3 Th is 
drug class takes its name from the fi rst barbiturate bar-
bituric acid, which was discovered and named by Ger-
man chemist Johann Adolf von Baeyer on 4 December 
1863 – the feast day of St. Barbara.4 
Barbiturate use became commonplace in Western 
society following the marketing of barbitone (brand 
name Veronal) in 1903.5  While barbiturates have prov-
en eff ective at inducing sleep, they have also been 
shown to cause a range of adverse eff ects such as un-
wanted daytime sedation, comas, and deaths, including 
the deaths of actresses Marilyn Monroe in 1962 and 
Judy Garland in 1969.6 Such a high potential for harm 
relates to the fact that barbiturates have narrow thera-
peutic indices; there is little diff erence between the dose 
required to eff ectively sedate a patient and the lethal 
dose.7 Th is refl ects the need in the fi rst half of the twen-
tieth century for safer alternatives to existing psycho-
tropic drugs.
During the 1950s, an event referred to as the ‘Psy-
chopharmacological Revolution’ forever changed the 
face of psychiatric practice.8 In December 1950, French 
chemist Paul Charpentier synthesised a medicinal sub-
stance called chlorpromazine.9 Over the next two years, 
this drug was trialled and found to relieve psychotic 
agitation, especially manic excitation.10 Chlorproma-
zine was fi rst marketed in December 1952 for the treat-
ment of psychiatric disorders and other indications, in-
cluding morning sickness.11 Th e drug was, and still is, 
marketed in Europe and Australia under the brand 
name ‘Largactil’. It soon became possible for people suf-
fering from psychiatric disorders to be successfully 
managed with chlorpromazine in the community rath-
er than being institutionalised.12 Chlorpromazine be-
came the world’s fi rst antipsychotic drug. Th e success 
of chlorpromazine in psychiatry gave birth to the fi eld 
of psychopharmacology and prompted the search for 
other targeted psychotropic drugs, with further antip-
sychotics and drugs such as tricyclic antidepressants 
and benzodiazepines becoming available in the 1950s 
and 1960s.13 Many of these newly available non-barbi-
turate psychotropic medicines had superior safety pro-
fi les to the earlier barbiturate drugs. Th is was a time of 
rapid change in the practice of psychiatry and pharma-
cy. 
Gender is an example of a demographic factor that 
could have infl uenced the uptake of new psychotropic 
medicines over the 1950s and 1960s. Compared with 
men, women may be less reluctant to seek medical at-
tention and more sensitive to market changes.14 In a 
prior study of prescription books kept in an English 
community pharmacy over the period 1890-1922, the 
drugs of dependence opium, cocaine, and heroin (legal 
substances at the time) were more likely to be dispensed 
to females than to males.15 Th ese results were not, how-
ever, adjusted for the sizes of the male and female pop-
ulations in the surrounding geographic area. Many of 
the male users of drugs of dependence in this historical 
study were returned servicemen who served in such 
countries as South Africa and India.16
While this study shed some light on gender diff er-
ences in the utilisation of drugs of dependence between 
the 1890s and 1920s, no known studies have examined 
gender diff erences in psychotropic use within a com-
munity pharmacy setting during the 1950s and 1960s 
– the period of the Psychopharmacological Revolution. 
Women may have been more likely than men to seek 
newly available treatments for mental health disorders, 
whereas returned servicemen with conditions such as 
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posttraumatic stress disorder may have also been regu-
lar users of psychotropics at this time. Such information 
is of interest in that it lays the foundation for the high 
levels of psychotropic use in modern day Australia. 
Modern day Australia has been found to have the sec-
ond highest consumption of antidepressants in the 
world,17 with women being signifi cantly more likely 
than men to use these medicines.18 An examination of 
psychotropic dispensing by gender in historic prescrip-
tion books could help trace the origins of psychophar-
macology in Australia.
Th is study aimed to examine gender diff erences in 
psychotropic medicine dispensing at an Inner South 
East Melbourne pharmacy during the Psychopharma-
cological Revolution of the 1950s and 1960s.
Methods
Data Source
Prescription books can be considered rich yet underu-
tilised sources of primary historical data on medicine 
dispensing.19 Prior to the availability of dispensing soft-
ware, prescription books were used to record all pre-
scribed medicines supplied to customers. Previously, 
prescription books dating from the 1850s,20 1860s,21 
1900s,22 and 1960s23 have been used to broadly describe 
the medicines dispensed in individual Australian phar-
macies. In the United Kingdom, meanwhile, prescrip-
tion books dating back to the nineteenth and twentieth 
centuries have been examined to better understand 
temporal changes in the use of diff erent dosage forms 
as well as the dispensing of drugs of dependence.24, 25, 
26, 27, 28
Th e data source for the present study is a pair of 
mid-twentieth-century prescription books that were 
kept at a community pharmacy in an inner south east 
suburb of Melbourne, Australia (Figure 1). Each book 
is bound in leather and measures 41 x 18.7 x 9.7 centi-
metres. Th e elder of the two books details prescription 
medicines dispensed over the period 25 November 1953 
to 1 June 1956, while the more recent book covers the 
period 20 May 1960 to 24 July 1963. Both volumes 
contain handwritten information on prescriptions dis-
pensed by several pharmacists, or pharmaceutical 
chemists as they were known at the time. Th e handwrit-
ten information includes patients’ titles, patients’ 
names, dispensing dates, medicines dispensed, costs, 
and directions for use. Th e pharmaceutical chemists 
wrote this information in ink on ruled pages, using the 
conventional academic language of Latin. Th e dis-
pensed prescriptions appear in each book in chrono-
logical order.
Study Design and Data Collection
A descriptive study was conducted to examine the vol-
ume of medicine dispensing over the calendar years 
1954 (book 1) and 1961 (book 2) by gender, prescrip-
tion type, and year. Th ese years were chosen to examine 
changes in psychotropic drug utilisation over a period 
coinciding with the rapid introduction of new psycho-
tropics (antipsychotics, benzodiazepines, and antide-
pressants) into the Australian market during the 1950s 
and 1960s. For each prescription recorded in the two 
books over the years 1954 and 1961, the following data 
items were collected: dispensing date, patient title, and 
name of medicine dispensed. Th e title of patients (e.g. 
Mr, Mrs, Sir, and Lady) was used as a marker of gender. 
Among all medicines dispensed, barbiturate psycho-
tropics, non-barbiturate psychotropics, and non-psy-
chotropic medicines were identifi ed using a published 
list of psychotropics in common use in 195929 as well 
as the editions of the British Pharmacopoeia30, 31 and 
Martindale: Th e Extra Pharmacopoeia32, 33 that were cur-
rent at the time. 
Inclusion and Exclusion Criteria
For each prescription, the inclusion criterion was med-
icine supply during the calendar years 1954 or 1961 
while the exclusion criteria were unknown gender (no 
title), a cancelled prescription, a prescription intended 
for veterinary use, and handwriting that could not be 
deciphered by a pharmacoepidemiologist with experi-
ence in community pharmacy.
Data Analysis
A descriptive analysis of eligible prescriptions was con-
ducted. Firstly, raw numbers of prescriptions dispensed 
in 1954 and 1961 were calculated and stratifi ed by pre-
scription type (barbiturate psychotropic, non-barbitu-
rate psychotropic, or non-psychotropic medicine), year 
of dispensing, and gender of the patient. Th e raw num-
bers were then adjusted for the size of the male and fe-
male populations resident in the local government area 
Figure 1. Th e prescription books used to source primary 
data
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(LGA) City of Stonnington – where the pharmacy was 
located – using Australian census data for the years 
195434 and 1961.35 What is now Stonnington com-
prised the cities of Malvern and Prahran during the 
study period. 
For each of the years 1954 and 1961, the ratio of 
prescriptions dispensed for females to prescriptions dis-
pensed for males was calculated across all prescriptions 
and for each prescription type. Additionally, for each 
year and gender, calculations were performed to deter-
mine the percentages of all prescriptions that were non-
psychotropics, barbiturate psychotropics, and non-bar-
biturate psychotropics, as well as the percentages of 
psychotropics that were barbiturates and non-barbitu-
rates. All calculations were performed in SPSS Version 
24 (SPSS Inc., Chicago, IL, USA) or Microsoft Excel 
2010 (Microsoft Corporation, Redmond, WA, USA).
Ethical Considerations
Ethics approval to conduct this research was obtained 
from the Monash University Human Research Ethics 
Committee, project 9523, approved 11 July 2017.
 Results
Between 2/1/1954 and 31/12/1954, 3,616 prescriptions 
were recorded in the elder of the two Melbourne phar-
macy ledgers. A total of 1,127 prescription records were 
excluded from the 1954 sample for a range of reasons, 
most commonly cancellation (Table 1). Th is left 2,489 
prescriptions in the fi nal 1954 sample for descriptive 
analysis. In the later period, between 3/1/1961 and 
29/12/1961, 2,783 prescriptions were recorded in the 
second Melbourne pharmacy ledger. A total of 1,317 
prescription records were excluded from the 1961 sam-
ple, primarily due to cancellation (Table 1), leaving 
1,466 prescriptions for the descriptive analysis. Be-
tween 1954 and 1961, the number of prescriptions fi lled 
at the Melbourne pharmacy fell by 41% from 2,489 to 
1,466. 




Cancellation 826 (73.3) 950 (72.1)
Indecipherable 135 (12.0) 134 (10.2)
Veterinary use 92 (8.2) 122 (9.3)
Unknown gender 
(no title)
47 (4.2) 23 (1.7)
Cancellation and 
veterinary use
27 (2.4) 86 (6.5)
Indecipherable and 
veterinary use
0 (0.0) 2 (0.2)
Total 1,127 (100.0) 1,317 (100.0)
Table 1. Reasons for excluding prescriptions from the 
1954 and 1961 samples




1954 1961 1954 1961 1954 1961
Number of prescriptions 
(unadjusted for population size)        
Barbiturate psychotropics 131 35 349 83 480 118
Non-barbiturate psychotropics 43 65 102 123 145 188
Non-psychotropics 566 396 1,298 764 1,864 1,160
Total 740 496 1,749 970 2,489 1,466
Total Local Government Area population36,37 45,568 46,016 55,351 54,408 100,919 100,424
Population size ratios 
(reference category: 1954 Males)
1.000 1.010 1.215 1.194
   
Number of prescriptions 
(adjusted for population size)        
Barbiturate psychotropics 131 35 287 70 418 104
Non-barbiturate psychotropics 43 64 84 103 127 167
Non-psychotropics 566 392 1,069 640 1,635 1,032
Total 740 491 1,440 812 2,180 1,304
https://doi.org/10.24355/dbbs.084-202007300931-0
68 PHARMACEUTICAL HISTORIAN  ·  2019  ·  Volume 49/3
When prescriptions in each year were stratifi ed by 
gender and prescription type, higher raw numbers of 
barbiturate psychotropic, non-barbiturate psychotrop-
ic, and non-psychotropic drugs were observed among 
females than males across both time periods (Table 2). 
Th ere was no evidence of any seasonal trend in psycho-
tropic dispensing for males, females, or persons over 
each of the years 1954 and 1961 (data not shown). As 
there were approximately 20% more females than males 
in the LGA City of Stonnington, adjustment of the pre-
scription numbers for population size led to a less pro-
nounced gender diff erence in prescription volumes. Fe-
males were dispensed more prescriptions in total, by a 
From 1954 to 1961, there were reductions in the raw 
volume of dispensing of barbiturate psychotropics and 
non-psychotropic medicines among males, females, and 
persons overall (Table 2). Th e raw volume of dispensing 
of the newer non-barbiturate psychotropics, however, 
rose among males, females, and persons overall between 
the study years. Th ese trends were maintained for each 
gender following adjustment for population size. While 
the number of diff erent generic barbiturate drugs dis-
pensed in 1954 and 1961 remained steady at seven, the 
number of diff erent generic non-barbiturates doubled 
from 19 to 38 over the seven-year period (Appendices 
A1-A4). 
Psychotropics as a proportion of all prescriptions 
dispensed was relatively stable across genders and years, 
ranging from approximately one-fi fth to one-quarter 
(Figure 3). Among males and females in 1954, barbitu-
rates constituted 19% of all prescriptions (Figure 3) and 
77% of psychotropic prescriptions (Figure 4). Seven 
years later, the volume of barbiturate dispensing had 
dropped by more than half to 8% of all prescriptions 
(Figure 3) and 38% of psychotropic prescriptions (Fig-
ure 4). Th e corresponding gender-specifi c proportions 
were 7% of all prescriptions and 35% of psychotropics 
for males, and 9% of all prescriptions and 40% of psy-
chotropics for females (Figure 3 and Figure 4). Th is re-
duction in barbiturate dispensing coincided with an 
increase in the dispensing of non-barbiturate psycho-
tropics, with the proportional volume rising from 6% 
to 13% of all prescriptions (Figure 3) and 23% to 62% 
of all psychotropics (Figure 4).  Th e rise in non-barbi-
























Figure 2. Female-to-male ratios of prescriptions dispensed 
in a Melbourne pharmacy, by prescription type and year, 
















Psychotropics as a % of all prescriptions Barbiturate pyschotropics as a % of all prescriptions
Non-barbiturate psychotropics as a % of all prescriptions
Figure 3. Psychotropics, barbiturate psychotropics, and 
non-barbiturate psychotropics as a percentage of all pre-
scriptions dispensed in a Melbourne pharmacy, by year and 
gender, based on population-adjusted prescription numbers 
(Table 2)
factor of 2 to 1 in 1954 and 1.7 to 1 in 1961 (Figure 2). 
Th is diff erential was maintained across prescription 
type. Females were dispensed more barbiturate psycho-
tropics, non-barbiturate psychotropics, and non-psy-
chotropics, by a factor of 1.6–2.2 to 1 (Figure 2).
Figure 4. Barbiturate psychotropics and non-barbiturate 
psychotropics as a percentage of all psychotropics dispensed 
in a Melbourne pharmacy, by year and gender, based on 

















Barbiturate psychotropics as a % of all psychotropics Non-barbiturate psychotropics as a % of all psychotropics
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Discussion
In 1954 and 1961, amidst the Psychopharmacological 
Revolution, the pharmaceutical chemists working at a 
Melbourne pharmacy dispensed more prescriptions to 
females than to males. Twice and 1.7 times as many 
prescriptions were dispensed to females in 1954 and 
1961, respectively. Gender diff erences of such magni-
tudes were observed in each year across three mutually 
exclusive categories of prescriptions: barbiturate psy-
chotropics, non-barbiturate psychotropics, and non-
psychotropics. Th ese results suggest that, at a particular 
Inner South East Melbourne pharmacy, females were 
supplied with more medications irrespective of wheth-
er or not the drugs were psychotropics intended to treat 
mental health disorders such as insomnia, anxiety, de-
pression, and schizophrenia. Th is fi nding fi ts with a 
historical study showing that, at an English pharmacy 
over the years 1890-1922, females were supplied with 
more opium, cocaine, and heroin – legal drugs at the 
time.38 Our fi nding is also consistent with modern day 
studies showing that women are more likely than men 
to visit GPs about health complaints in general.39-41
While psychotropics as a percentage of all prescrip-
tions remained relatively stable over time, the observed 
decline between 1954 and 1961 in barbiturate dispens-
ing at the Melbourne pharmacy is striking. Th e per-
centage of psychotropic prescriptions that were barbi-
turates dropped by more than half from 77% to 38%, 
with similar percentages observed for both males and 
females. Th e drop in barbiturate dispensing suggests 
that, between 1954 and 1961, these relatively unsafe 
psychotropic drugs were falling out of favour with pre-
scribers. At the same time, the volume of dispensing of 
the newer, safer non-barbiturate psychotropics nearly 
trebled from 23% of psychotropics to 62% of psycho-
tropics. Th is likely refl ects the gradual uptake of the 
wide range of psychotropic drugs that were developed 
and marketed during the Psychopharmacological Rev-
olution of the 1950s and 1960s. Th erefore, by 1961 in 
this particular Melbourne pharmacy, non-barbiturate 
psychotropics had started to be used in preference to 
barbiturate psychotropics. Our results suggest that fe-
male customers were no more sensitive to these market 
changes than male customers. Th e shift in psychotrop-
ic drug utilisation from barbiturates to non-barbiturates 
has not been previously quantifi ed in the literature.
Th e use of ratios and proportions in our study min-
imised the impact of the Melbourne pharmacy’s decline 
in overall dispensing volume between 1954 and 1961. 
Th e number of total prescriptions dispensed over this 
period fell by 41% from 2,489 to 1,466, potentially due 
to increased competition from nearby pharmacies. Data 
collected from the Pharmaceutical Register of Victoria 
suggest that, in the particular suburb where the phar-
macy was located, the number of registered pharmaceu-
tical chemists increased by 32% from 28 in 195142 to 
37 in 1963.43 Patients who fi lled their prescriptions at 
the pharmacy in our study during 1954 may have tak-
en their business to one of the new pharmacies operat-
ing in the suburb during 1961.  
A strength of this quantitative study is the use of 
prescription books as primary sources of data on dis-
pensing volumes in a Melbourne pharmacy. As pre-
scription books needed to be maintained by all phar-
macies for fi nancial purposes prior to the availability of 
dispensing software, the primary data used for this 
study are likely to be accurate and complete. An addi-
tional strength over prior historical studies of prescrip-
tion books,44-51 including the study that assessed the 
gender diff erence in dispensing of drugs of depend-
ence,52 is the adjustment of results for the population at 
risk in the pharmacy’s geographic location.
Th is study also has a number of limitations. While 
the prescription books state the titles and names of the 
customers to whom drugs were dispensed, they do not 
indicate if the drugs were in fact used and who ended 
up taking them. For example, a woman may have ob-
tained a prescription medicine that was later used by a 
male partner or a dependent instead. If this were the 
case, then our results would be more indicative of 
healthcare seeking behaviour than drug utilisation. Th e 
cancellations observed across all prescription types re-
duced the sizes of the samples available for analysis; 
however, the sample sizes were still high at 2,489 and 
1,466 for 1954 and 1961, respectively. A further limita-
tion, relative to a modern day pharmacoepidemiologi-
cal study conducted using electronic dispensing data, 
is the potential for errors in the reading of pharmaceu-
tical chemists’ handwritten prescriptions. Th e potential 
for such errors was mitigated through the exclusion of 
records where the drug name was uncertain. Addition-
ally, our fi ndings may have limited generalisability be-
yond the particular Melbourne pharmacy where the 
prescription books were kept.
Our fi ndings suggest several future directions for 
research.  As the study was conducted in only one Mel-
bourne pharmacy, there is a need for additional research 
to confi rm whether our fi ndings are generalisable to 
other pharmacies over the period of the Psychopharma-
cological Revolution of the 1950s and 1960s. Another 
avenue is to examine the volume of barbiturate psycho-
tropic dispensing before and after the deaths of celebri-
ties from barbiturate overdose. Prescription rates in our 
study were not infl uenced by the news of Monroe or 
Garland dying from barbiturate overdose as the study 
period preceded these tragedies.
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Appendix A1. Number of barbiturate psychotropics dispensed in 1954 by generic name of drug and gender
Male Female Total
Generic Name Number % Number % Number %
Phenobarbital 85 64.9 215 61.6 300 62.5
Barbital 11 8.4 40 11.5 51 10.6
Pentobarbital 12 9.2 27 7.7 39 8.1
Secobarbital and amobarbital 7 5.3 18 5.2 25 5.2
Butobarbital 7 5.3 16 4.6 23 4.8
Secobarbital 4 3.1 17 4.9 21 4.4
Amobarbital 5 3.8 16 4.6 21 4.4
Total 131 100.0 349 100.0 480 100.0
 Male Female Total
Generic Name of Drug Number % Number % Number %
Promethazine 10 23.3 27 26.5 37 25.5
Chloral hydrate 8 18.6 13 12.7 21 14.5
Hyoscine 4 9.3 17 16.7 21 14.5
Reserpine 5 11.6 12 11.8 17 11.7
Dexamphetamine 4 9.4 12 11.7 16 11.0
Methylpentynol 0 0.0 8 7.8 8 5.5
Amphetamine 4 9.4 2 2.0 6 4.2
Chlorobutanol 0 0.0 4 3.9 4 2.8
Paraldehyde 3 7.0 0 0.0 3 2.1
Valerian 3 7.0 0 0.0 3 2.1
Chlorpromazine 1 2.3 1 1.0 2 1.4
Apronal 0 0.0 1 1.0 1 0.7
Bromvaletone 0 0.0 1 1.0 1 0.7
Lithium 1 2.3 0 0.0 1 0.7
Mephenesin 0 0.0 1 1.0 1 0.7
Methylamphetamine 0 0.0 1 1.0 1 0.7
Pyrithyldione 0 0.0 1 1.0 1 0.7
Unknown 0 0.0 1 1.0 1 0.7
Total 43 100.0 102 100.0 145 100.0
Appendix A2. Number of non-barbiturate psychotropics dispensed in 1954 by generic name of drug and gender
Overall, our research fi nds that, at a pharmacy in 
the Inner South East region of Melbourne in 1954 and 
1961, females were dispensed more barbiturate psycho-
tropics, non-barbiturate psychotropics, and non-psy-
chotropics than males. Among psychotropics, there was 
a sharp shift in dispensing from the barbiturates to 
newer, safer non-barbiturate drugs between 1954 and 
1961, irrespective of gender.
Authors’ addresses: Michael James Leach , School of 
Rural Health, Monash University, PO Box 666, Ben-
digo, VIC 3552, Australia. Email: Michael.Leach@
monash.edu.
Rebecca Kippen, School of Rural Health, Monash Uni-
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Appendix A4. Number of non-barbiturate psychotropics dispensed in 1961 by generic name of drug and gender
Male Female Total
Generic Name of Drug Number % Number % Number  %
Phenobarbital 18 51.4 52 62.7 70 59.3
Barbital 6 17.1 9 10.8 15 12.7
Amobarbital 6 17.1 17 20.5 23 19.5
Secobarbital and amobarbital 2 5.7 3 3.6 5 4.2
Butobarbital 1 2.9 1 1.2 2 1.7
Secobarbital 2 5.7 0 0.0 2 1.7
Pentobarbital 0 0 1 1.2 1 0.8
Total 35 100 83 100.0 118 100.0
Appendix A3. Number of barbiturate psychotropics dispensed in 1961 by generic name of drug and gender
 Male Female Total
Generic Name of Drug Number % Number % Number %
Trifl uoperazine 5 7.7 14 11.4 19 10.1
Chlordiazepoxide 5 7.7 12 9.8 17 9.0
Promethazine 9 13.8 8 6.5 17 9.0
Pipradrol 4 6.2 8 6.5 12 6.4
Th alidomide 4 6.2 7 5.7 11 5.9
Chloral hydrate 6 9.2 4 3.3 10 5.3
Reserpine 4 6.2 5 4.1 9 4.8
Tranylcypromine 1 1.5 8 6.5 9 4.8
Meprobamate 2 3.1 6 4.9 8 4.3
Imipramine 4 6.2 3 2.4 7 3.7
Amfepramone (diethylpropion) 0 0.0 6 4.9 6 3.2
Arsenic 3 4.6 3 2.4 6 3.2
Promazine 2 3.1 3 2.4 5 2.7
Amphetamine 3 4.6 1 0.8 4 2.1
Dexamphetamine 0 0.0 4 3.3 4 2.1
Dichloralphenazone 1 1.5 3 2.4 4 2.1
Methylpentynol 3 4.6 1 0.8 4 2.1
Phenmetrazine 2 3.1 2 1.6 4 2.1
Prochlorperazine 2 3.1 2 1.6 4 2.1
Glutethimide 1 1.5 2 1.6 3 1.6
Isopropamide and trifl uperazine 1 1.5 2 1.6 3 1.6
Chlorpromazine 1 1.5 1 0.8 2 1.1
Diethylcathinone 0 0.0 2 1.6 2 1.1
Methylphenidate 0 0.0 2 1.6 2 1.1
Perphenazine 0 0.0 2 1.6 2 1.1
Amitriptyline 1 1.5 0 0.0 1 0.5
(continued)
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A R T I C L E
Four pharmacy education entrepreneurs 
in Victorian Britain: Robert Clay (1792-
1876), John Abraham (1813-1881), John 




Th is article profi les four Victorian entrepreneurs who 
founded three private schools of pharmacy in Great 
Britain. Th e fi rst private school of pharmacy was found-
ed in Liverpool by Robert Clay, John Abraham and the 
Liverpool Chemists Association in 1849, in response to 
the formation of the Pharmaceutical Society of Great 
Britain in 1841. Th e second private school of pharmacy 
was founded by John Muter in London in 1872 (the 
fi rst private school of pharmacy in London); and the 
third private school of pharmacy was founded by 
George Wills in London in 1874 (the largest and most 
successful private school of pharmacy in London). Mut-
er and Wills saw the need for more education establish-
ments following the mandatory requirements of the 
Pharmacy Act 1868.
Introduction
Th e Victorian Age in Great Britain – the period during 
which Queen Victoria reigned (1837-1901) – was a pe-
riod of rapid change and growth. Th ere were rapid ad-
vances in scientifi c, medical and technical fi elds and 
also a rise in literary works.1 Th e railways developed and 
this opened up the country, as people fl ocked to the cit-
ies for work. Peoples’ leisure expanded and changes 
were seen in the population’s growth and location. Th e 
industrial revolution pushed Great Britain into global 
prominence, yet despite this there was social inequality 
which in turn initiated social reform.2
Pharmacy too was to undergo rapid change. Th e 
Pharmaceutical Society of Great Britain was founded 
by a group of prominent chemists and druggists in Lon-
don in 1841, in order to protect their trade from un-
qualifi ed practitioners. In the early nineteenth century 
anyone could practice as a chemist and druggist, and 
unqualifi ed practitioners were threatening the jobs of 
the qualifi ed.3 
Th e founders of the Pharmaceutical Society initial-
ly laid down educational standards that were voluntary, 
but Jacob Bell, the Society’s founder, hoped that they 
would become compulsory through a Pharmacy Act 
(1852). Th ere was a preliminary examination before in-
denture as an apprentice,4 and the Minor or Major ex-
amination had to be taken prior to qualifi cation. Suc-
cess in the Minor examination qualifi ed the candidate 
to be an assistant chemist and druggist, and to be eli-
gible for Associate membership of the Society. Before 
taking the Major examination a candidate needed to be 
in business or to be intending to commence in business, 
so an assistant needed to pass in order to progress.5 Th e 
Major and Minor examinations came in at the same 
time in 1841-43. In the 1852 Pharmacy Act, examina-
tion success lead to the award of the title Pharmaceuti-
cal Chemist but members of the Pharmaceutical Soci-
ety did not need to be Pharmaceutical Chemists to join 
it or stay in membership/registration. 
However, British chemists and druggists in the 
mid-nineteenth century regarded themselves as trades-
men, and were fi rm believers in free trade. Many were 
reluctant to accept compulsory education, examination 
and registration.6 As well as resistance from current 
practitioners, there were other obstacles in establishing 
a country-wide system of pharmaceutical education, for 
there was no national system of technical or scientifi c 
education, and the major cities had few resources.7 It 
was mainly left to local groups or individual entrepre-
neurs to meet the need.
Th e fi rst schools of pharmacy  
To off er a means of proper education and instruction 
the Pharmaceutical Society opened a school of phar-
macy in Bloomsbury in 1842, but this was only acces-
sible to those living in London.8 In Liverpool a group 
of prominent chemists and druggists were working to 
the same goal. Th ey were members of the Liverpool 
Chemists’ Association that had been formed in 1849, 
and they aspired to set the educational standards for 
pharmacy in Liverpool. A private school of pharmacy 
– the Liverpool School of Pharmacy – was founded in 
1849. Robert Clay and John Abraham, who were busi-
ness partners in the Liverpool fi rm of Clay and Abra-
ham, were among the founders.
With passage of the Pharmacy Act 1868 the Minor 
examination became mandatory as the qualifying ex-
amination for registration as a chemist and druggist.9 
Under the Act the Pharmaceutical Society was given 
the responsibility of devising and conducting the Mi-
nor examination. However, there were critics of the Act 
who stated that compulsory examination only led to 
students learning just enough to pass the examination. 
Critics of the private schools said that students were 
passing the examinations after six weeks, after learning 
model questions and answers. In 1872 Professor John 
Attfi eld of the Pharmaceutical Society’s School of Phar-
macy reported that the 1868 Act was having a negative 
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eff ect on pharmacy, making the sole goal of students 
that of passing the Minor examination in order to reg-
ister as Chemists and Druggists. Th is was encouraging 
cramming, and with cramming there was damage be-
ing done to the ideals of pharmaceutical education.10 
Th ere was also a problem with providing pharma-
ceutical education on a nationwide basis.11 To help with 
this problem the Pharmaceutical Society made small 
discretionary grants to local pharmaceutical associa-
tions, to enable them to organise courses of lectures. 
Critics said this would encourage the entrepreneur, and 
that this would lead to the emergence of ‘proprietary’ 
or private schools of pharmacy, which were labelled as 
‘cram’ schools, or the ‘bottom line in schooling’.12 
Yet these private schools of pharmacy did improve 
the means of study, as they were specifi cally geared to 
preparing students for the qualifying Minor examina-
tion.13 Th e schools’ existence depended on the success 
of the students and the number of passes in the Minor 
examination. In London, a need emerged for private 
schools of pharmacy which just off ered ‘cramming’ 
courses to prepare people for the qualifying examina-
tions, rather than the extensive programme off ered by 
the Society’s school of pharmacy. John Muter and 
George Wills were two of the entrepreneurs who re-
sponded to this need by forming their own private 
schools in London: the South London School of Chem-
istry and Pharmacy (Muter) and the Westminster Col-
lege of Chemistry and Pharmacy (Wills). 
Th is article presents brief profi les of four of the men in-
volved in forming these private schools of pharmacy in 
Victorian Britain.  
Robert Clay (1792-1876)
Robert Clay, who was born in 1792, was the senior 
partner in the fi rm of Clay and Abraham, a chemists 
and druggists’ business that had been formed in 1845. 
Mr Clay gave his attention to the manufacturing side 
of the business.14 Earlier in his career Clay, at the age of 
21, worked as a druggist at 4 Ranelagh Street, Liver-
pool,15 when he established the fi rm of Messrs Clay & 
Dodd & Co. in 1813, a manufacturing business.16  Th e 
business carried on for many years under the style of 
Messrs Robert Clay & Co. He was joined by Mr Hen-
ry Case, an apprentice of the Liverpool Apothecaries’ 
Company, and the name of his fi rm changed to Clay, 
Dodd & Case. Th e business then reverted again to the 
style of Clay, Dodd & Co. Th e company was later 
bought by Evans Medical Supplies Ltd in 1920.17 In 
1835 there were 128 druggists recorded in Liverpool.18 
Robert Clay had worked at William Allen’s Plough 
Court Pharmacy (later owned by Allen & Hanburys) 
in London.19 On 30 May 1836, Robert Clay ‘was a 
moving spirit’ in the organisation of the Liverpool 
Apothecaries Company, which was founded with a cap-
ital of £100,000.20 Robert Clay was the manager of the 
Liverpool Apothecaries’ Company and he wrote 
I hereby certify that I have been actively engaged in 
the business of a chemist and druggist in Liverpool 
for the last thirty-four years and am able to declare 
from my personal experience that the scientifi c and 
professional measures daily practised in the estab-
lishment of the Liverpool Apothecaries Company 
with the view of securing pure drugs for medical 
purposes are most necessary in order to protect the 
medical profession and the public from adulteration 
practised in the manufacture, preparation and com-
pounding of drugs. 
Th e premises of the Liverpool Apothecaries’ Company 
were at 4 Colquitt Street, and were known as the Liv-
erpool Apothecaries’ Hall. Th ey comprised a ware-
house, chemical and pharmaceutical laboratories and 
retail shops, erected at a cost of £30,000. Robert Clay 
devised the machinery by which its chemical and phar-
maceutical preparations were to be manufactured.21 
The Liverpool Apothecaries’ Company became a 
Figure 1. Robert Clay (1792-1876) (Source: Portrait 
kindly supplied by Roger Hull, Liverpool Record Offi  ce) 
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branch of the General Apothecaries Company which 
existed from 1856-1859. Th e Liverpool Apothecaries’ 
Company failed ‘to obtain Letters Patent’ and ‘strug-
gled to make a return for investors’. To make matters 
worse there were competitors. In 1860 the Liverpool 
Apothecaries’ Company went into voluntary liquida-
tion.22
Robert Clay was nominated to be the fi rst president 
of the newly formed Liverpool Chemists’ Association 
on 8 June 1849.23 Prior to 1849 and before the found-
ing of the Pharmaceutical Society of Great Britain in 
London in 1841 ‘the chemists and druggists of Liver-
pool had been a disparate and disorganised group’.24 
Jacob Bell, the president of the Pharmaceutical Society 
came to Liverpool, to discuss the formation of the 
Chemists Association. However, it was decided that the 
Liverpool Chemists Association would be an independ-
ent body and not a branch of the Pharmaceutical Soci-
ety. 
Th e Liverpool School of Pharmacy was founded in 
1849 ‘as an off shoot of Jacob Bell’s idea to form a Liv-
erpool branch of the Pharmaceutical Society’.25 Th e 
Liverpool Chemists’ Association evolved and initiated 
lectures that were held in the Royal Institution in 
Colquitt Street, (still the headquarters for the Associa-
tion). Th ere were classes, a library, a laboratory and a 
museum of materia medica. Th e Liverpool Chemists’ 
Association was successful in growing medicinal plants 
at Liverpool’s Botanic Gardens, where they gave week-
ly lectures and supplied specimens to the classes.26 
Robert Clay died on 7 January 1876. He had vast ex-
perience as a scientifi c manufacturer, as a drugs whole-
saler and as a successful chemist and druggist, all of 
which enabled him to make an extremely valuable con-
tribution as a founder of the Liverpool school of phar-
macy.
John Abraham (1813-1881)
John Abraham was the junior partner of Clay and 
Abraham, and he ran the dispensing side of the busi-
ness. Th e business achieved a Royal Warrant to supply 
chemists’ requisites to Queen Victoria. Abraham was 
born in Carlisle in 1813 and became an important 
pharmacist in Liverpool where he was the acknowl-
edged ‘doyen of pharmacy in that city’. Like Clay, he 
had worked at Plough Court Pharmacy (later owned by 
Allen & Hanburys) in London.27 In 1838 he was ap-
pointed head of the dispensing department of the Liv-
erpool Apothecaries’ Company. 
His term of offi  ce there explains his friendship with 
Dr David Waldie, who had also joined the Liverpool 
Apothecaries’ Company in 1839, as a manufacturing 
chemist.28 Dr Waldie had perfected a method to sepa-
rate pure chloroform dissolved in a known volume of 
spirit but his work on chloroform was interrupted by 
two fi res at Apothecaries Hall. Dr Waldie continued 
his work at the home of John Abraham at 87 Bold 
Street.29 John Abraham resigned from the Liverpool 
Apothecaries Company in 1843.
John Abraham’s philanthropic and political activi-
ties saw him associated with many learned societies in 
Liverpool. He was treasurer and later president of the 
Polytechnic Society, he was on the committee of the 
Lyceum News-room, and he was president of the spe-
cial committee set up in 1849 to monitor the progress 
of cholera in Liverpool. He was also honorary secretary 
for 25 years, and later co- president, of the Female Pen-
itentiary. He was a founder of the Naturalists’ Field 
Club and later its treasurer. He was president of the Liv-
erpool Microscopical Society, which later became the 
Liverpool Natural History and Microscopical Society. 
He was involved in forming the Gallery of Inven-
tions and Science in connection with the Free Library 
and Museum. He was a director of the Liverpool Insti-
tute and Queen’s College and later president. He served 
on the committee of the Royal Society for the Preven-
tion of Cruelty to Animals (RSPCA).30 John Abraham 
was also president of the Liverpool Chemists’ Associa-
Figure 2. John Abraham (1813-1881) (Source: Chemist 
and Druggist.1881; 23: 148)
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tion in 1856, 1857 and again from 1869 to 1871.31 He 
had served for four years (1867-71) on the Council of 
the Pharmaceutical Society of Great Britain and was 
one of its examiners. He was also the fi rst president of 
the Liverpool Registered Chemists and of the Liverpool 
Chemists’ Early Closing Associations.
Th e Liverpool Chemists’ Association soon estab-
lished itself as a force in pharmacy, and when in 1885 
the head of chemistry for the School of Pharmacy re-
signed from this position, the Council of the Liverpool 
Chemists’ Association appointed committees to ap-
prove the curriculum and arranged for a continuance 
of the revised curriculum. Clay and Abraham’s names 
occurred regularly in the minutes of those meetings.32 
Th e Liverpool School of Pharmacy (established in 
1849) thrived, and (by 1885) ‘this purely private school 
had developed into an offi  cially recognised institu-
tion’.33 John Abraham was an experienced chemist and 
druggist and an administrator with a wealth of phar-
maceutical and scientifi c knowledge, which made him 
well-placed to found the Liverpool’s School of Phar-
macy on a fi rm footing. Th e Liverpool school was the 
United Kingdom’s last surviving private school of phar-
macy. Even though the pupil numbers had fallen by 
half during the Second World War, it remained a pri-
vate school until 1953. In 1970 it merged with the Re-
gional College of Technology. In 1971 it became part 
of Liverpool Polytechnic, and today it is part of Liver-
pool John Moore’s University.34 
John Abraham died in March 1881. Th e retail busi-
ness of Clay and Abraham continued until 1969.35
Dr John Muter (1841-1911)
In 1872 Dr John Muter opened the South London 
School of Chemistry and Pharmacy at 289 Kennington 
Road, London. It was the fi rst private school of phar-
macy in London. Muter was born in Glasgow in 1841. 
His father was Dr J. D. Muter, who was professor of 
materia medica at the Portland Street Medical School, 
Glasgow. On his mother’s side he was related to the 
founder of the Glasgow Society of Apothecaries. By 
profession Muter was a chemical analyst, not a pharma-
cist. He studied at Glasgow University for several years 
and subsequently attended the medical curriculum pro-
vided at the Andersonian University, studying chemis-
try and anatomy. 
Muter was awarded several prizes and certifi cates in 
chemistry classes. He became an assistant to Dr Penny, 
the professor. However, he had a serious illness which 
forced him to stop work. On partial recovery he trav-
elled to France, Germany and Austria. He took the de-
gree of PhD at the University of Rostock in northern 
Germany. Muter realised that the Pharmaceutical So-
ciety’s School of Pharmacy could not cope with the 
number of candidates applying for the Minor examina-
tion and with the fi nancial incentive off ered by the 
Pharmaceutical Society he became the fi rst person in 
London, outside the Pharmaceutical Society’s School 
of Pharmacy, to tackle the necessity for qualifi cation as 
a result of the Pharmacy Act 1868. He began to prepare 
pupils for examination and in 1868 ‘from a small be-
ginning he started teaching pupils to qualify them’.36 
Later in 1873, his School of Chemistry and Phar-
macy moved to a newly built school at 325 Kennington 
Road.37 An advert in 1875 showed the South London 
School of Chemistry and Pharmacy; it off ered educa-
tion to ‘Class A students’ who were those who could 
study up to ten months continuously. ‘Class B students’ 
were those who had already obtained privately a knowl-
edge of the subjects, who ‘desired to perfect their stud-
ies and were yet unable to remain in London for longer 
than three months’.38 
Th e private schools were popular and good value for 
money. Th ey concentrated courses to three months to 
enable students to pass the examinations. Th eir courses 
were held in the evenings and were easier to attend than 
full-time courses. At this school there were prizes, med-
als and certifi cates of attendance, and merits were 
awarded to ‘diligent students’.  
John Muter stated that, because the Minor exami-
nation was easy to cram for, he taught it in an intensive 
way. However, his intention was to provoke a change in 
order to make the examination more thorough. When 
this was achieved, he changed his teaching methods. 
Many in pharmacy were grateful for John Muter’s thor-
ough tuition. An example of his students’ gratitude was 
seen 
Figure 3. John Muter (1841-1911) (Source: Chemist and 
Druggist.1911; 79: 57 Index Folio 929)
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On 12 July 1875, this being the closing day of lec-
tures for the summer season at the South London 
School of Chemistry and Pharmacy. Th e students of 
the pharmacy class assembled to present Dr Muter 
with a handsome and richly- chased silver inkstand 
bearing a suitable inscription, in token of his untir-
ing energy in promoting their education. Some time 
ago the lecturer on pharmacy and materia medica 
had died and his position and his place had been 
fi lled temporarily. Th e latter gentleman, having been 
unwell for some weeks, Dr Muter immediately of-
fered to lecture on the whole subjects taught at the 
School. He carried out the arduous task so that there 
was some extra reason for students to mark their rec-
ognition for Dr Muter’s zeal and ability as a teach-
er.39
Th e Chemist and Druggist recorded that “Th is was not 
the fi rst testimonial by many that Dr Muter has re-
ceived”.40 Th e confi dence of the South London School 
of Chemistry and Pharmacy was seen in a large adver-
tisement in 1879, which promoted their facilities with 
a picture of a new laboratory. Th e advertisement boldly 
stated ‘For the eleventh session 1879-1880, a laboratory 
the most elegantly fi tted in Great Britain’. It also stated 
‘1,200 living witnesses to its success on the role of the 
chemist’, and fi nally ‘the Directors continue to spare no 
expense in giving the greatest facilities and in provid-
ing the most competent lecturers, so as to ensure the 
student both present success and permanent benefi t in 
after life’.41 
Later South London School of Chemistry and Phar-
macy was known as ‘Muter School of Pharmacy’. In the 
1870s there was opposition to women in pharmacy and 
the women students found it diffi  cult to obtain instruc-
tion in a chemical laboratory, until Dr Muter opened 
his laboratories to them. Th e Muter’s School produced 
several noteworthy women pharmacists, such as Louisa 
Stammwitz and Rose Minshull. Miss Stammwitz – 
along with Rose Minshull and Mrs Alice Hart – signed 
a petition to allow female students access to the Soci-
ety’s chemical laboratories. It was not until after they 
had passed their Minor examinations that the Pharma-
ceutical Society’s School of Pharmacy opened their lab-
oratories to women.42 
Following the Technical Instruction Act of 1889 
there was competition from public establishments that 
were dedicated to teaching pharmacy. Th ere were two 
new Polytechnics in South London; the South Western 
Polytechnic Institute on Manresa Road in Chelsea, and 
the Battersea Polytechnic, on Battersea Park Road. By 
5 December 1900 the South London School of Chem-
istry and Pharmacy Limited went into liquidation.43 
Muter’s vast experience as a scientist and researcher 
was shown in his research publications during the years 
1877-1900. He had fi fteen memoirs on the analysis of 
food published in Th e Analyst, a journal which he co-
founded (1877) and co-edited (1877-91).44 His knowl-
edge and determination made him a very capable 
founder of a private school of pharmacy. 
 John Muter carried on working as a public analyst 
for six London boroughs until his death in 1911.45 Th e 
Muter’s School of Pharmacy was resurrected in 1904 
and continued until 1924, having been renamed Th e 
London College of Chemistry, Pharmacy and Botany, 
incorporating the South London School of Pharmacy 
(Muter’s).46 Th e building at 325 Kennington Road re-
mains today; the front of the building is an estate 
agents.
Figure 4. George Wills (1842-1932) (Source: Kurzer, 
Frederick. Medical History. 2007; 51: 499)
George Wills (1842-1932)
George Sampson Valentine Wills was born in Roade, 
Buckinghamshire near Stony Stratford on 14 February 
1842. His ancestors had been builders and his great 
grandfather had been a stone mason. He was educated 
at the British School in Stony Stratford and also attend-
ed the town’s chapel where he played the organ. He 
loved music all through his life. On leaving school he 
worked with a local eccentric who practised ‘physic 
’among the country folk. Wills made simple remedies 
which were used by the ‘physic’ healer. 
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Wills increased his knowledge of plant and drug 
lore through reading. He was apprenticed to a chemist 
and druggist in the town. Th e business changed hands 
twice in quick succession and Wills was transferred 
along with the stock. His second employer, Mr Benja-
min Bullus, took an interest in Wills’ progress and ap-
pointed him as assistant in a new venture at Hookley 
Hill, Birmingham. In 1870 Wills worked in similar 
positions in Hay-on-Wye, Barrow-in-Furness and 
Folkestone.47 
After two years of private study Wills passed his 
Minor examination in 1873.48 After this he applied for 
the position of dispenser in the medical practice of Dr 
C. F. DuPasquier, Apothecary to the Queen’s House-
hold. Wills obtained the post out of sixty other appli-
cants but a problem arose when it was realized that 
Wills did not hold the Dispenser’s Certifi cate of Apoth-
ecaries’ Hall, which was in fact inferior to the Minor 
examination but in DuPasquier’s eyes it was an essential 
for Royal Service. Wills assured DuPasquier that he 
would pass the necessary examination for the Apothe-
caries’ Hall Certifi cate in three days without further 
study. Th e examination was held weekly and Wills 
passed. 
Wills had plenty of free time in this new employ-
ment and in this time he devised a system of postal in-
struction to help young colleagues in the provinces who 
struggled to study for the qualifying examinations. 
Wills’ postal scheme was an instant success and this 
encouraged him to resign from his post with Dr Du-
Pasquier and change his career to teacher and educa-
tionist.49 
Th e Westminster College of Chemistry and Phar-
macy 
Wills founded the Westminster College of Chemistry 
and Pharmacy in October 1874 in his house at 133 St 
George’s Road Lambeth. At fi rst only two rooms were 
fi tted up as laboratories and the number of pupils was 
small but soon more rooms were used for teaching. 
When the whole house was taken up for teaching, two 
more adjoining houses in nearby Lambeth Road were 
added.50 Meanwhile George Wills passed the Major ex-
amination in 1876.51 Due to further growth, the college 
then transferred to two large Halls in North Street 
Kennington. Th e college now added a disused Baptist 
Chapel in Trinity Street Southwark in 1882, which 
held 100 students.  In the chapel, two galleries were 
Figure 5. Westminster College lecture hall c.1890 (Source: Kurzer, Frederick. Medical History. 2007; 51: 486)
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levelled and enclosed. Th ey were fi tted up as a chemical 
laboratory with 74 work places along one wall and 
smaller rooms for practical work along the other wall. 
Th e lecture Hall accommodated extra students but for 
practical and special subjects the class was split into fi ve 
groups.  
Th ese groups were rotated each term. On three eve-
nings a week, part-time students studied until 9pm.52 
Th e work of the postal system continued behind the 
scene. Th e syllabus used was prescribed by the Pharma-
ceutical Society. Th e lectures were illustrated with dem-
onstration experiments, large diagrams and charts 
which were drawn on to calico wound on to rollers. 
Biological drawings were done by Wills’ eldest daughter 
Georgina, who was a trained artist and designer.53 Th ere 
were strict rules at the College especially regarding 
punctuality and safety in the laboratory. Students had 
to absorb and memorise a lot of factual information as 
well as having practical sessions. Dispensing included 
the deciphering of doctors’ prescriptions.54 
Th ere were weekly tests and end of term examina-
tions with medal and certifi cate prizes off ered. Th e fees 
were moderate, the costs in 1899 of the Minor Course 
was 8 guineas per term reduced to 12 guineas for two 
terms payable in advance. One payment of 15 guineas 
secured tuition until qualifi ed. Th e cost for the Major 
examination was 6 guineas per term. Th e postal cours-
es cost one guinea for a full course of 100 lessons sent 
in 50 instalments, postage costs were small and spread 
over one year or more, access to this postal tuition was 
available to all.55 Up to sixty students from outside Lon-
don could stay in approved full- board accommodation 
for 1 guinea per week. Th e loss of potential earnings 
during full-time study discouraged many candidates 
and they would use the College’s evening classes, at the 
low cost of 1 guinea for one evening a week per term or 
use the postal courses.56 
After three years Westminster College was the larg-
est of its kind in London and had achieved nearly as 
many examination passes as all the other schools in 
England put together. It had achieved this result when 
more than half of the candidates regularly failed the 
Minor examination. By 1900, Westminster College of 
Chemistry and Pharmacy had enabled 4000 chemist 
and druggists to successfully register with the Pharma-
ceutical Society, out of a total of 16,000 nationwide.57 
Westminster College continued to be successful but 
in 1908 a fi nancial disaster occurred. Wills had estab-
lished a pharmacy business in 1898 near his home in 
South Croydon. Th e venture was not a success and 
Wills lost his house and his personal assets. Th e failure 
resulted in the voluntary liquidation of Westminster 
College, which had been registered as a limited com-
pany in 1901. Th e disruption of the College lasted a few 
months and Wills soon resurrected the Westminster 
College at new premises at 402 Clapham Road, Lam-
beth, a neighbourhood which by 1908 already had fi ve 
other private schools of pharmacy nearby. Between 
them the six private schools supplied the greater part of 
the privately trained pharmacists for the entire coun-
try.58 Th e other private schools of pharmacy are listed 
in Table 1. 
Th e Westminster College of Chemistry and Phar-
macy moved to 190 Clapham Road in 1918. During 
the Second World War between 1939 and 1945, the site 
of Westminster College at 190 Clapham Road, was de-
stroyed by bombs.59 Th e last advertisement for the Col-
lege appeared in the Chemist and Druggist in August 
1939, where it stated that ‘the School now specialises 
solely by revision and preparatory work by post’.60 
George Wills was the author of two dozen text-
books and manuals on the pharmaceutical syllabus.61 
He had great knowledge and skill as a teacher and ad-
ministrator. He also had endless energy for work which 
made him ideally suited to be the founder of this suc-
cessful private school of pharmacy. Wills remained in 
sole charge of the College up to the age of 76. He died 
on 28 April 1932 aged 84. 
Conclusion
Pharmacy entrepreneurs played a crucial role in shap-
ing the education of pharmacy students. Th e four pro-
fi led here used their skills and experience to set about 
founding three of the private Schools of Pharmacy es-
tablished during the Victorian era. In 1849 Robert 
Clay and John Abraham, together with other mem-
bers of the Liverpool Chemists Association, founded 
the Liverpool School of Pharmacy. Nineteen years lat-
er, following the 1868 Pharmacy Act, the qualifying 
examinations of the Pharmaceutical Society of Great 
Britain became compulsory. Th e Society’s own School 
of Pharmacy could not cope with the large number of 
students who needed to prepare for the qualifying ex-
aminations. John Muter started teaching a few pupils, 
and in 1872 he established the South London College 
of Chemistry and Pharmacy. Two years later George 
Wills founded the Westminster College of Chemistry 
and Pharmacy.
Th ese private schools of pharmacy provided the op-
portunities to enable students to achieve the manda-
tory qualifi cations that followed the Pharmacy Act of 
1868. Th e education and examination of pharmacy stu-
dents became the bedrock for the professionalization of 
pharmacy in Great Britain. Th e personalities of these 
founders of the schools of pharmacy played a major role 
in the success of the private schools of pharmacy.
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S H O R T  C O M M U N I C A T I O N
Four Nuremberg medicinal weights 
recovered from the wreck of the 




In June 1676 the Swedish royal ship KRONAN per-
ished into the Baltic Sea in an explosion off  the east 
coast of Öland, while engaged in a battle against an al-
lied Danish-Dutch fl eet. Th e discovery of the ship’s 
wreck in 1980 marked the start of a marine-archaeo-
logical project that to date has produced nearly 35,000 
objects. It constitutes a peephole straight into many as-
pects of late-seventeenth century Swedish society. 
Among the plethora of fi nds, a pharmaceutical-medic-
inal context has been recognised, comprising about 200 
items so far. Th e present contribution focuses on the 
identifi cation of four medicinal weights recovered from 
the wreck site over a period of thirteen years. Th e 
weights are fully characterized with respect to type and 
size, and traced to their production site, manufacturer, 
and approximate year of production. 
Zusammenfassung
Im Juni 1676 sank das königlich schwedische Kriegs-
schiff  KRONAN im Gefecht gegen die vereinigte nied-
erländisch-dänische Flotte in der Ostsee aufgrund ein-
er Explosion an der Ostküste Ölands. Das im Jahr 1980 
entdeckte Wrack des Schiff es markierte den Beginn 
eines meeresarchäologischen Projekts, bei dem bis heu-
te circa 35 000 Objekte geborgen wurden. Der Fund 
bietet ein Guckloch geradewegs in die verschiedenen 
Aspekte einer Gesellschaft des 17. Jahrhunderts. Unter 
der Vielzahl an Objekten sind bis heute über 200 Ein-
träge zusammengetragen worden, die in einen 
pharmazeutisch-medizinischen Kontext gehören. Dies-
er Beitrag beschäftigt sich mit der Identifi kation von 
vier medizinischen Gewichten, die über einen Zeitraum 
von 13 Jahren von dem Wrack geborgen wurden. Die 
Stücke werden vollständig nach Typ und Größe be-
schrieben. Zusätzlich wird Fragen zum Herstellung-
sort, der Manufaktur sowie dem Zeitfenster nach-
gegangen.
Introduction
On 1 June 1676 the Swedish Navy was hit by one of its 
greatest ever disasters when one of its men o’ war, the 
royal ship KRONAN (‘Th e Crown’), perished into the 
Baltic Sea in an explosion off  the east coast of Öland. 
Th is mark of disgrace occurred during a skirmish with 
an allied Danish-Dutch fl eet, and is attributed to bad 
seamanship within the Swedish squadron. Th e redis-
covery of the ship in 1980, at a depth of 28 metres and 
a position 3.4 nautical miles due east of the village of 
Hulterstad on southeast Öland, marked the start of a 
marine-archaeological project in 1981 directed by the 
Kalmar County Museum.1  Shipwrecks like that of the 
KRONAN refl ect societies in miniature, and it was im-
mediately realised that such a closed fi nd constituted a 
peephole straight into numerous aspects of late-seven-
teenth century society. With 850 people (albeit all men) 
on board, the KRONAN constituted a fl oating society 
in terms of both crew numbers and social structure, 
during a period when there was rarely any clear distinc-
tion between military and civilian society.2
Underwater work on the KRONAN has taken place 
for three to four weeks every summer since 1981, and 
so far has produced around 35,000 fi nds. Among this 
plethora of objects, a pharmaceutical-medicinal context 
has been uncovered which so far comprises about 200 
items. Th is communication presents the identifi cation 
of four medicinal weights, recovered as isolated fi nds 
from the wreck site over a period of thirteen years (Fig-
ure 1).
Figure 1. Detail of the site plan of the KRONAN, show-
ing the distribution and relative location of the medicinal 
weights KLM 12091KR:187, KLM 13848KR, KLM 
13929KR and KLM 17274KR. (Source: Drawing: Lars 
Einarsson/Kalmar County Museum)
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Medicinal weight systems
Th e apothecaries’ weight system – which was to become 
the one predominantly used in several areas of the Eu-
ropean continent by apothecaries in the composition of 
medicinal drugs – had its hub in Nuremberg, where it 
was established by medical regulation in 1555. Th e sys-
tem pertains to information given in the Dispensatori-
um by the German-born physician and natural scientist 
Valerius Cordus (1515-1544).3 Th e standard for the 
Nuremberg pharmaceutical weight, 1 libra, (the apoth-
ecaries’ pound) was composed of 12 ounces, the latter 
being divided in turn into drachmas, then into scruples, 
and fi nally into grains, as follows: 
1 libra  356.28 grams
1 ounce 29.69 grams twelve to the libra
1 drachma 3.71 grams eight to the ounce 
1 scruple 1.24 grams three to the drachma
1 grain 62 mg twenty to the scruple
Th e reference standard was the ounce made in silver 
that was kept secure in the city hall of Nuremberg. In 
Sweden the system was introduced in the 1660s. Its use 
was ratifi ed in the Medical Ordinance of 1688 and then 
applied until 1869, when it was abandoned due to the 
introduction of the metric system of measurements by 
a new royal ordinance.4
Medicinal weights deposited in the Baltic
Th e wreck site of the KRONAN comprises a plethora 
of objects that have been deposited in the sand at the 
bottom of the Baltic for more than 300 years. Of the 
items salvaged over the years, the pharmaceutical-me-
dicinal items constitute quite an extensive collection.5 
Th is closed context consists of partly destroyed small 
cabinets and chests, along with numerous solitary fi nds. 
Today, taken together these make up an astonishing 
catalogue of 200 entries, dominated by cases and jars 
containing drugs. Finds of medical instruments and 
tools are proportionately few, but from among the large 
quantities of odds and ends, classed as solitary fi nds, 
four apothecary’s weights (Figure 1) have now been rec-
ognized as true pharmaceutical-medicinal artefacts.
Th e fi rst weight to be discovered (KLM 12091:187 
KR) was recovered in 1999 from the ship’s orlop deck. 
It originated from part of a closed fi nd context in the 
form of a wooden chest (KLM 12091:1 KR) comprised 
of no less than 253 artefacts of diff erent types. Th e 
weight is listed as a piece of metal in the divers’ log. Th e 
fi rst consideration of the fi nd as being an apothecary’s 
weight was based upon its form and size. It measured 
18.5 x 18.5 mm at the base and 13 x 13 mm at the top, 
with a height of 14.5 mm; it weighed – encrustations 
included – 29.76 grams (Figure 2). After scrutiny, this 
proved to be in accord with a one-ounce weight (nom-
inal weight 29.69 grams). 
Figure 2. Th e 1 Ounce  (KLM 12091:187, left) and the 
½ Ounce (KLM 17274KR, right) weights prior to conser-
vation. (Source: Photo by Stina Damberg/Kalmar County 
Museum, 6a)
Four years later, in 2003, this was followed by the 
discovery of two smaller weights, with the appearance 
of the two-scruple weight (nominal weight 2.48 grams). 
One (KLM 13848 KR) was heavily corroded, while the 
other (KLM 13929 KR) exhibited an almost mint con-
dition. It measured 16.5 x 19.3 mm, with a thickness of 
1.7 mm, and a weight of 2.38 grams (Figure 3b). Its 
lower right “horn” bears signs of fi ling by an adjuster.
Both scruples were found in the ship’s hold, and the 
distance between the deposits was 2½-3 metres. Th e 
distance between the better-preserved scruple (KLM 
13929 KR) and the ounce (KLM 12091:187 KR) was 
only 0.5 metres (Figure 1). Th e latest weight (KLM 
17274 KR) so far discovered was compatible with a 
half-ounce (nominal weight 14.84 grams). It was an 
isolated fi nd on the lower deck, fi ve to seven metres 
away from the other weights (Figure 1). It was not re-
trieved until the summer of 2013, some fourteen years 
after the discovery of the fi rst weight. Its dimensions 
were 14.5 x 14.5 mm at the base and 10.5 x 10.5 mm at 
the top, with a height of 12.5 mm; it weighed 15.21 
grams, encrustations included (Figure 2). All of the 
weights were assumed to be made of brass.
Th e objects were subjected to cleaning in a series of 
stages, in accordance with applicable standard proce-
dures. From the very outset, the mark “C W” or “G W” 
was perceptible on the non-corroded two-scruple 
weight, and after careful mechanical cleaning it became 
clearly visible as “C W” within an oval. Th e golden 
brass surface was restored by further cleaning, using the 
metal-complex former, EDTA (Figure 3b). Th e half-
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ounce and the ounce were then subjected to careful me-
chanical cleaning, whereupon marks became succes-
sively visible on their bases. 
Th e ounce weight was clearly marked with the es-
tablished symbol for an ounce followed by the Roman 
numeral I, for one; while the half-ounce weight was 
marked with exactly the same symbol but followed by 
an s, representing semi, the Latin word for half (Fig-
ure 3a). Both weights carried the mark “C W” within 
an oval, clearly visible and in a similar fashion to the 
scruple. Th e half-ounce (KLM 17274 KR) weighed 
14.45 grams after cleaning; the ounce (KLM 12091:187 
KR) weighed 29.13 grams. 
Analysis of the metal composition of the weights 
was performed at ALSAC laboratories in Uppsala, Swe-
den. Th e alloys were analysed using a Shimadzu EDX 
fl uorescence spectrometer. Results are summarised in 
Table 1.
Th e provenance of the medicinal weights
Th e style of the makers’ mark is consistent with a 
Nuremberg source. However, due to Swedish trading 
connections at the time, the possibility that these 
weights could have originated from Antwerp or else-
where in the Low Countries could not be disregarded. 
Conceivable information in contemporary historical 
source material was searched for, in an attempt to as-
certain the origin of the weights. It became evident that 
the mark “C W”, that appeared on all of the weights, 
was that belonging to Christoph Weinmann, a weight-
maker active in Nuremberg at this actual time. Accord-
ing to Lockner, Weinmann used a wolf conjoined with 
the letters “C W” arranged vertically inside an oval, or 
the letters by themselves inside an oval.6 Weinmann 
used these stamps as his maker’s mark from 1667 on-
wards. Additional information in the Nürnberger Kün-
stlerlexikon states that he became a master craftsman 
Figure 3. Th e ½ Ounce (KLM 12091:187, 3a left) and the 2 Scruple (KLM 13929KR, 3b right) weights after conser-
vation with the maker’s mark “CW”  clearly visible. (Source: Photo by Stina Damberg and Max Jahrehorn, respective-
ly/Kalmar County Museum)


















(KLM 13929 KR) 70 13 7.7 3.3 3.2 1.0 0.9 2.4g
1 Ounce weight
(KLM 12091:187 KR) 33 50 1.8 2.6 5.5 0.2 0.3 29.8g
½ Ounce weight
(KLM 17274 KR) 32 50 4.3 4.9 5.9 0.8 0.9 15.2g
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in 1657, and in 1669 a sworn master craftsman (“ge-
schworener”), which means that he then supervised 
production quality in Nuremberg.7 
Th e results from the analysis of the alloys, which, at 
present, are applicable only to their surfaces, should be 
regarded as approximate and indicative, rather than 
conclusive. With a copper content of 70 per cent the al-
loy of both two-scruples appears to be closest to that 
denoted for brass, while the alloys of the ounce and the 
½-ounce contain surprisingly high amounts, 50 %, of 
lead. 
Th ere are diff erences in their production: the ounc-
es have been moulded directly, while the much smaller 
scruples are cut off  larger pre-moulded billets. Th e dif-
ference can be noted already on visual inspection. De-
spite the fact that the registered weights do not deviate 
substantially from the designated ones (see above), after 
more than 300 years in the Baltic, the eff ects of corro-
sion have to be taken into account. 
Th e weights that occur in the medicinal context at 
the wreck site of the KRONAN originate from Nurem-
berg, where they were made by the master brass-smith 
and weightmaker, Christoph Weinmann. According to 
what we know about his maker’s mark, these weights 
must have been cast in 1667 or later, though before the 
warship’s disastrous naval campaign. Th e KRONAN 
was launched on 31 July 1668. However, things moved 
slowly and with the ship moored at Skeppsholmen, the 
naval shipyard in Stockholm, the fi tting was still ongo-
ing in the summer of 1674. Th e KRONAN participat-
ed in her fi rst naval campaign in the autumn of 1675.8 
Perceivably the weights were among the medicinal 
goods brought aboard the ship just prior to this cam-
paign. 
Th e archeologically retrieved weights, as tokens of 
medical activity on board the KRONAN, have now 
been fully characterized with respect to type and size 
of weight, and they have been traced to their site of pro-
duction and manufacturer. Moreover, we know that the 
maximum time-span from casting until they sank into 
oblivion was eight years. However, these pieces of in-
formation, rendered possible by this look through a 
keyhole into June 1676, raise some additional questions. 
Why were there medicinal weights on board the KRO-
NAN in the fi rst place? Who were the actors responsi-
ble for taking them on board? Why were they of foreign 
make – produced in Nuremberg – and not of domestic 
manufacture?
Discussion
Medicinal weights are intended to be used solely in the 
handling of drugs, for example in the preparation of a 
remedy according to a given prescription. Th is is a task 
undertaken by an apothecary or a barber-surgeon. At 
the time of the provision of the KRONAN, the doctor 
of the Admiralty was Peter Schallerus (16??-1676), a 
Swede educated at Uppsala University. He was respon-
sible for the organisation of medical service in the Navy, 
and he was assisted in this task by the apothecary of the 
Admiralty, Alexander Stecker (16??-1676) and its bar-
ber-surgeon, Herman Fuchs (1620-1676).9 Like most 
apothecaries of this period (see below), the latter two 
were both Germans with well-established networks. 
When the KRONAN sank Schallerus and his two col-
leagues were on duty on board and perished, to become 
recorded as missing in action.
Th us, we fi nd these leaders of the Navy’s medical 
professions among the 800 lives lost. Fuchs and Steck-
er were members of the German community in Stock-
holm. Fuchs was born in Hamburg and started his ed-
ucation as barber-surgeon in Stettin. Notably, at the age 
of eighteen, he became a barber-surgeon under the pa-
tronage of the Swedish councillor Gabriel Oxenstjerna 
(1619-1673), and in 1641 he started his engagement 
within the Swedish army. He held the position of bar-
ber-surgeon, and was posted to three Swedish embas-
sies: with Count Magnus Gabriel De la Gardie (1622-
1686) to France; with Eric Gyllenstjerna (1602-1657) 
to Moscow; and with Count Nils Brahe (1633-1699) to 
England. He was on duty at the Siege of Prague before 
being recruited to the navy in 1654.10
In the year 1682, Stockholm was credited with hav-
ing 947 craftsmen, 284 of whom were foreign, appren-
tices included.11 Five pharmacies were in operation in 
the city in the 1670s;  notably, four of them were run 
by Germans.12 Th e Guenon Pharmacy (1623) was 
owned by George Christion Dauer from Prague, the 
Angel Pharmacy (1649) by Christopher Molitor from 
Cassel, the Swan Pharmacy (1650) by Samuel Ziervogel 
from Mansfi eld, and fi nally the Blackamoor Pharmacy 
(1670) by Christian Heraeus (1643-1691), a native of 
Güstrow. All later became naturalized Swedish citizens. 
Notably, some of them moved from what had become 
Swedish provinces at the time. From the very begin-
ning, Swedish apothecaries were part of a culture which 
was fi rmly grounded in the world of German cities and 
towns; their spheres of infl uence and activity were in-
dependent of territorial borders, at least within the 
Protestant segment of Europe.13 
Christian Heraeus, recognized for his learning, 
came to Sweden under the patronage of the Swedish 
Lord High Constable Carl Gustaf Wrangel (1613-
1676). As a member of Wrangel’s court he arrived in 
Sweden in 1669. He was the son of a physician in the 
family of Count Johan Alberecht II of Mecklemburg-
Güstrow.14 Christian Hereaus ended up as a court 
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apothecary, and eventually as personal physician to the 
queen dowager, Hedvig Eleonora. Investigations of 
contemporary historical documents in war archives re-
veal that, while the medicine chests and canisters were 
prepared by the carpenters at the naval shipyard, the 
contents of these medicine chests should be delivered 
preferentially by Christian Heraeus at the Blackamoor 
Pharmacy, that was later to become designated ‘Phar-
macy of the Admiralty’.15
Th rough his engagement in the Th irty Years’ War, 
Carl Gustaf Wrangel became an important Swede on 
the European arena. He governed part of the newly ac-
quired provinces (the Swedish Vor-Pomerania) of the 
Swedish realm. Together with others (see above), as a 
magnate he was instrumental in establishing countless 
foreign contacts all over Europe; in his capacity as a sig-
nifi cant patron, he could attract learned men and 
knowledge from abroad.16 He did not even hesitate to 
act on medical matters. On one occasion during his ap-
pointment as Admiral of the Navy, he himself ordered 
medicinal supplies from Amsterdam.17 Th e order con-
tained 95 diff erent items to be used in the Polish War 
in 1655. Th is order was made at the time when both 
Peter Schallerus and Herman Fuchs were under his 
command. During the Nuremberg Peace Congress in 
1649-1650 Wrangel built numerous contacts in that 
free city, notably Jacob Barth and Johann Eggerdt, who 
assisted him in various businesses of an offi  cial as well 
as a private nature.18
From the fourteenth century and into the Th irty 
Years’ War, Nuremberg was an important craft centre 
within Europe.19 It was a free city (not to be ruled by 
the kings of Bavaria) and despite Catholic surroundings 
it remained Protestant. A Protestant city like Nurem-
berg was going to be a supporter of Gustav II Adolph 
(1505-1632), and its ties to the Swedes grew stronger 
following the Battle of Breitenfeld in 1631. 
Spanning over the early modern period, there were 
around 200 weight-producing workshops in the city. 
For the brass-smiths, Nuremberg was a “closed shop” 
during the sixteenth and early seventeenth century, 
which meant that no apprentices were allowed other 
than those born to burghers of the city. Th is explains 
why, when looking for our weight-maker “C W” dur-
ing this period, we astonishingly encountered more 
than fi fty Weinmanns denoted as Nuremberg brass-
smiths or weight-makers. Th e latter produced weights 
according to local European weight standards. 
Th e fi rst Swedish brass factory was founded in 1571 
and seven brass producers, including manufacturing 
units, were in operation around 1670.20 Th ey were all 
owned and managed by a tight-knit network of indi-
viduals originating from families in Amsterdam, Ant-
werp and the industrialized borderland around Aachen, 
many of whom eventually became naturalised Swedish 
citizens.21 Th e enterprise developed into a monopoly, 
infamous for its “Swedish brass barons”. 
Th us, Sweden’s brass production did not originate 
from Nuremberg and even though a domestic produc-
tion of utility goods made from brass became plentiful 
in the seventeenth century, precision objects like the 
renowned Nuremberg nested cup weights were import-
ed. Th is import successively decreased during the eight-
eenth century as production was taken over by skilled 
local weight-makers, especially in Stockholm. Since 
most craftsmen and merchants were at this time for-
eigners, it was not unlikely for an occasional one from 
Nuremberg to make an appearance.22 Th e guild of the 
brass-makers in Stockholm was founded on 27 June 
1720, but the casting of nested weights did not start 
until 1760. 23
Apart from the medicinal weights, there are other 
exclusive objects found in the wreck of the KRONAN 
to be classifi ed as Nuremberg metalware. Th ese include 
a folding sundial, a trumpet and a set of nested cup 
weights (KLM 12091:227 KR). Th e sundial was a very 
early discovery, found in the beginning of the 1980s, 
and it carries the master’s mark “B H” ascribable to Bar-
ent Henrickle, active in Nürnberg around the turn of 
the sixteenth century.24 Th e trumpet was found on the 
middle deck of the ship. It is a somewhat sophisticated 
orchestral instrument made in Nurnberg in 1654, as-
cribable to the celebrated maker Michael Nagel.25 It has 
not yet been possible to connect the merchant’s nested 
cup weights to a specifi c maker in the city.
Conclusion
On the supply side, one could easily draw on several 
Swedish-German trading networks that had connec-
tions with the producers of the well-known and cele-
brated Nuremberg metalware. The weights were 
brought on board the KRONAN as regular medical 
objects to be used in composing medicinal remedies on 
board. It may well be that Alexander Stecker or Her-
man Fuchs brought a scale together with a cassette of 
medicinal weights on board as part of their personal 
belongings. A further medical artefact that was found 
at an earlier stage, located in the vicinity of the scruples, 
is a hemi-spherical wooden bowl used for gilding pills.26 
Th e latter, as well as the medicinal weights, manifest 
social and material superiority.
Even if we do not know who acted as the tradesman 
in supplying these medicinal weights, their discovery 
and identifi cation, and the fact that they were to be 
used onboard the KRONAN, provide one explicit ex-
ample that not only illustrates but confi rms cultural 
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exchange within the medicinal sphere between Nurem-
berg and Stockholm in the mid-1600s. Sweden not only 
adopted the medicinal weight system of Nuremberg, 
but the pharmacies in Stockholm also became a market 
for Nuremberg ware in the early modern period. As far 
as is known, these are the oldest weights of their kind 
that exist in Sweden.
Acknowledgements
Th e author would like to express his thanks to Lars Ei-
narsson, Stina Damberg, Max Jahrehorn at Kalmar 
County Museum for  enjoyable cooperation and crea-
tive discussions in the evaluation of the archaeological 
fi nds; and to Ilja Zelikman at Alsac, Uppsala, for the 
determination of the metal compositions. I am very 
much indebted to Hjalmar Fors, Uppsala University, 
for fruitful discussions with respect to cultural ex-
change in the development of early modern medicine 
in Sweden; to Dr Patrick Cassitti, University of Bam-
berg, for his help in tracking down the provenance of 
the weights; and to Dr Simone Kahlow, Berlin for lin-
guistic assistance. Th e work was supported by grants 
from Apoteket AB and the Swedish Academy of Phar-
maceutical Sciences, which are gratefully acknowl-
edged.
Authors Address: Professor Emeritus Björn Lindeke, 
Swedish Academy of Pharmaceutical Sciences, Box 
1136, SE-111 81 Stockholm. e-mail: bjorn.lindeke@tel-
ia.com. 
Endnotes and References
1. Einarsson, L. Regalskeppet KRONAN – Historia och 
arkeologi ur djupet. Lund: Historiska Media, 2016.
2. Einarsson, L. Artefacts from the KRONAN (1676): cat-
egories, preservation and social structure. In: Mark, R. (ed.) Ar-
tefacts from Wrecks. Exeter: Oxbow Monograph 84. 1997: 209-
218.
3. Cordo, V. Dispenstorium pharmacorum omnium quam 
chymicorum. Nuremberg: Johannis Andrae Endteri and Wof-
gangi Junioris Haeredum, 1666.
4. Jansson, S.-O. Måttordboken. Stockholm: Nordiska mu-
seets förlag, 1995: 26.
5. Lindeke, B. and Ohlson, B. With the warship KRO-
NAN in the wake of Paracelsus - Archaeological fi nds refl ecting 
the conception of drugs in 17th century Sweden. In: Kahlow, S. 
(ed.). Transfer between sea and land. Maritime Vessels for cultural 
exchange in Early Modern Period.  Leiden: Sidestone Press, 2018: 
63-86.
6. Lockner, H. Die Merkzeichen der Nürnberger 
Rotschmiede.  Munich: Deutscher Kunstverlag, 1981: 825.
7. Grieb, MH. (ed.)  Nürnberger Künstlerlexicon. Munich: 
K. G. Sauer, 2007.
8. Einarsson, L. (Note 1) 2016: 71-86.
9. Zettersten, A. Svenska fl ottans historia. åren 1635-1680. 
Norrtelje: Norrtälje Tidning, 1903: 549-550.
10. Sacklén, JF. Sveriges läkarehistoria ifrån konung Gustaf 
I:s till närvarande tid, I. Nyköping: 1822: 350.
11. Sjögren, O. Karl den elfte. Ett 200-årsminne. Stock-
holm: Frölen & Comp. 1897: 415.
12. Fors, H. Medicine and making of a city: Spaces of phar-
macy and scholarly medicine in seventeenth-century Stockholm. 
ISIS. 2016; 107: 473-494.
13. Fors, H. (Note 12) 2016: 479.
14. Hammarlund, A. Ett äventyr I staten – Carl Gustav Her-
aeus 1671-1725. Stockholm: Carlssons, 2003: 30-36.
15. Swedish War Archives. Protocols of the Admiralty. 1679-
01-17.
16. Losman, A. Carl Gustaf Wrangel och Europa. Lychnos 
bibliotek, Stockholm 1980.
17. Swedish War Archives. Protocols of the Admiralty. 1655-
03-12.
18. Losman, A. (Note 16) 1980: 56-71.
19. Gadd, J. Brass basins and bowls from a single Nurem-
berg workshop around 1500-1580. Journal of the Antique Metal-
ware Society. 2008, 16: 2-18.
20. Forsgren, N. Mässingsbruk och bruk av mässing, Borg-
holm: Nifo förlag, 2010: 8-11.
21. Forsgren, N. (Note 20) 2010: 141-147. 
22. Oscarsson, I. Den franske kammartjänarens resa, Stock-
holm: Atlantis, 2013 : 173, transcription of Ms.1143, Mémoires 
d’un voyage fait dans les pays septentrionaux en l’an MDCLX-
III. Bibliothèque municipale/Médiathèque, Orleans.
23. Kungl, Majt. Förnyade algemene ordning och skrå för 
hantvärckare i Swerige och Finland 1720. Stockholm 1741.
24. Werner, G. Johansson, L.-U. Skåpets föremål: bläck-
penna M/1676. In Johansson, B. A. (ed). Regalskeppet KRONAN, 
Höganäs: Bra Böcker, 1985, :244-245.
25. Einarsson, L. (Note 1) 2016: 274-277.
26. Lindeke, B., Ohlson, B., Einarsson, L. and Jahrehorn, 
M. Gilded pills in the medical chest on board the warship KRO-
NAN. Journal of Nordic Archaeological Science 2009; 16: 25-31.
https://doi.org/10.24355/dbbs.084-202007300931-0
 PHARMACEUTICAL HISTORIAN  ·  2019  ·  Volume 49/3 89
S H O R T  C O M M U N I C A T I O N
Fatma Belkis Derman (1906-1958): Th e 
fi rst female community pharmacist in 
Turkey
Halil Tekiner and Afi fe Mat
Abstract
After graduating from the Istanbul University School 
of Pharmacy in 1930, Fatma Belkis Derman (1906-
1958) left her mark on the history of pharmacy as the 
fi rst female pharmacist in Turkey to set up a pharmacy, 
operate a laboratory, and receive a license for a propri-
etary medicine in her own name. Despite various ob-
stacles and even disdain amongst the locals of her time, 
she made women pharmacists visible and respectable in 
Turkey, paving the way for Turkish women to pursue 
pharmaceutical careers. 
Introduction
Th e involvement of women in the pharmaceutical pro-
fession has a long but chequered history. From Saint 
Hildegard of Bingen, a twelfth-century Benedictine ab-
bess and herbalist polymath, to Spanish pharmacist Dr 
Carmen Peña, the fi rst female president of the Interna-
tional Pharmaceutical Federation (FIP) in 2014, we 
fi nd pharmacy greatly indebted to women.1, 2 Some of 
the pioneers are the fi rst women to graduate from 
schools of pharmacy, such as Mary Corinna Putman 
(1842-1906) in the USA (1863) and Andréine Doume-
rgue (1844-1877) in France (1874); as well as the fi rst 
female presidents of pharmaceutical societies, such as 
Isabella Clarke-Keer (1843-1926) from the Association 
of Women Pharmacists (UK; 1905) and Jean Irvine 
(1877-1962) from the Royal Pharmaceutical Society of 
Great Britain (1947-1948).3, 4, 5
However, limited historical information remains in 
the literature addressing women’s achievements in, or 
contributions to, pharmacy, particularly in non-West-
ern countries. In order to contribute to bridging this 
gap, the current paper seeks to present the fi rst compre-
hensive biography in English of Fatma Belkis Derman, 
the fi rst female community pharmacist in Turkey, on 
the sixtieth anniversary of her death. Th e study was un-
dertaken using primary reference sources obtained 
from her descendants, together with several other ar-
chival records and biographical sources. 
Th e admission of Turkish women to health profes-
sions
Aside from the fi elds of midwifery and nursing, Turk-
ish women’s admission to the study of medicine began 
during the First World War (1914-1918), presumably 
due to lack of medical professionals, many of whom 
were serving at the Front.6 Although the Şûra-yı Devlet 
(the Ottoman Council of State) had made a decision in 
1898 that disallowed women from studying medicine, 
a small number of Turkish women went abroad to be-
come physicians. An early example is Safi ye Ali Hanım7 
(Krekeler; 1894-1952), who went to Germany in 1916 
to study medicine at Würzburg University and returned 
to Turkey in 1922.8 
Th e situation remained unchanged for nearly two 
decades until 1917, when the Sıhhiye Meclis-i Umûmi-
si (the General Board of Health) amended the previous 
ban, allowing women to study medicine in Turkey. 
Nonetheless, it was after enduring struggles that female 
students were given permission to register at the Tıp 
Fakültesi (the Faculty of Medicine) in 1921, which was 
put into eff ect a year later.9 Similar attempts were also 
made in the fi eld of dentistry; Ayşe Şâdiye Hanım 
(Güvendiren; 1904-??) and Hatice Azrâ Hanım (1897-
??) became the fi rst dentists to graduate in 1926. Addi-
tionally, the fi rst female Turkish physicians graduated 
two years later.10
With regard to pharmacy, the situation was 
somewhat similar. During the Ottoman Empire, al-
though formal pharmacy education was off ered for 
the fi rst time at the Mekteb-i Tıbbiye-i Adliye-i 
Şâhâne (the Imperial School of Medicine) in Istanbul 
in 1839, female students were allowed to enrol at the 
Eczacı Mektebi (the School of Pharmacy) only after 
1922.11 It was, however, only in September 1924 that 
Ayşe Saâdet Hanım became the fi rst female student 
to enrol in the School of Pharmacy, although she quit 
after six weeks. Other students followed her in en-
rolling to the same school, but either failed classes 
because the courses were discontinued or transferred 
their registrations to other schools of the same uni-
versity, mostly the Faculty of Medicine and the 
School of Dentistry. Among these was Fatma Belkis 
Hanım (Derman at marriage), who was in fact the 
fi fteenth female student to register at the School of 
Pharmacy, but who would be one of the fi rst to grad-
uate.12
Th is fl ourishing of women’s rights was in fact most-
ly due to the reforms implemented by the Young Re-
public, founded in 1923 under the leadership of Kemal 
Atatürk (1881-1938), that encouraged girls to receive 
education and to be actively involved in the commu-
nity, giving special importance to women’s rights (i.e. 
adoption of the Swiss Civil Code in 1926, voting rights 
in local elections in 1930, full universal suff rage in 
1934, and the election of female deputies to the Turk-
ish Parliament in 1935).13
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Biography of Fatma Belkis Derman
Fatma Belkis Derman was born in İzmit, Turkey, in 
1906 to parents who had immigrated from Belgrade 
and Vidin.14 Although she had initially aspired to be-
come a teacher during her years at Erenköy Kız Lisesi, 
a respected high school for girls in Istanbul, and even 
had attended the related teaching courses, she changed 
her mind to pursue a career in pharmacy and registered 
to the Istanbul University School of Pharmacy (under 
the Faculty of Medicine) on 17 September 1927, with 
student number 294 (Figure 1).15
Completing her three-year studies there, and an in-
ternship at the Sırrı Enver Pharmacy in the Fatih dis-
trict of Istanbul, she graduated in June 1930 (Figure 2). 
Th us she qualifi ed as one of the fi rst female pharmacists 
in the country, together with Ayşe Semiha Hanım (Er-
çin; 1907-??) and Fatma Bedriye Hanım (Siren; 1910-
2007), two sisters, who would later become assistants 
at the departments of organic chemistry and biochem-
istry of the School of Pharmacy, respectively (Fig-
ure 3).16, 17 
Because of Law No. 694 that mandated limiting the 
number of pharmacies in accordance with the popula-
tion, allowing one pharmacy in a district per 10,000 
inhabitants, Fatma Belkıs Hanım went to Adapazarı, a 
city where her family resided. She worked there for a 
short period of time as a commercial partner of phar-
macist Ömer Bey’s community pharmacy, before set-
ting up her own Belkıs Eczâhânesi (the Belkıs Phar-
macy) in Düzce in 1931. Th us she became the fi rst 
female community pharmacist in Turkey.18, 19
In an interview she gave to Yeni Gün newspaper in 
1931, Fatma Belkis Hanım stated that she was rather 
occupied with her pharmacy work. Although being 
much welcomed by the sole doctor of the district and 
local women there, some male villagers had doubts 
Figure 1. Fatma Belkis Derman when she was a student 
at the School of Pharmacy in Istanbul, late 1920s. (Source: 
Courtesy of the Derman Family)
Figure 2. Th e pharmacy diploma of Fatma Belkis Derman, 
given by the Istanbul University Faculty of Medicine on 
31 July 1930. (Source: Courtesy of the Istanbul Univer-
sity Faculty of Pharmacy)
Figure 3. Fatma Belkis Derman (fi rst left) together with 
her two female classmates, Ayşe Semiha Erçin (second left) 
and Fatma Bedriye Siren (third left), at the School of Phar-
macy in Istanbul, ca. 1930. (Source: Courtesy of the Der-
man Family) 
https://doi.org/10.24355/dbbs.084-202007300931-0
 PHARMACEUTICAL HISTORIAN  ·  2019  ·  Volume 49/3 91
about her fi lling their prescriptions. She was even told 
of men standing outside of her pharmacy, waiting for 
the pharmacist instead of his presumed daughter. Fat-
ma Belkis Hanım further stated that thanks to her 
strong commitment and keen observation skills, she 
was successfully able to integrate with local culture and 
become very familiar with the medical slang of the lo-
cal patients, who called diseases and medications by 
diff erent and mostly incomprehensible names.20 
Interestingly, even several decades before the growth 
of patient-centred care in modern pharmacy practice, 
with remarkable foresight Fatma Belkis Hanım stated 
in the same interview that 
besides medications, I often give a lot of advice to 
my patients. I like my profession much more for be-
ing a confi dant to most of them. Day by day, I bet-
ter understand that comforting patients and their 
relatives, giving them hope, encouragement and em-
powerment, is of much more importance than sole-
ly giving medications.21
Fatma Belkis Hanım married Hasan Derman (1904-
1971), a 1927 pharmacy graduate and later president of 
the Türkiye Eczacılar Cemiyeti (the Turkish Pharma-
ceutical Society), and she moved to Istanbul in 1932.22 
Th e following year, she took over the Ahmet Süreyya 
Pharmacy at no. 22 Ördeklibakkal Street in the 
Kumkapı district where she would operate until Febru-
ary 1939. She then ran the İstanbul Eczanesi (the Istan-
bul Pharmacy) at no. 33 Tramvay Street in the 
Bahçekapı district (jointly with pharmacist Kemal Ata-
bey), after the owner of this pharmacy, pharmacist 
Agop Minasyan, died in August 1941 (Figure 4).23 
February 1944, she did not adapt well to this job and 
soon quit. Instead, she operated her ongoing Istanbul 
Pharmacy alone from 1947 until her fi nal years. Suff er-
ing from chronic rheumatism and hypertension for 
many years, she died from heart disease on 26 July 
1958.26 Her pharmacy was then operated by her hus-
band for three more years, until it was sold in 1961 to 
Leman Başkur-Kazuk (1918-2012), another pioneer fe-
male pharmacist.27
Fatma Belkis Derman was known by many of her 
colleagues as a candid, aff ectionate, vivid, cheerful and 
stylish person with high human and traditional values 
as well as an enthusiastic, meticulous, hard-working 
pharmacist and an ideal mother.28, 29 She was for many 
years socially active with charities and local founda-
tions, such as the Foundation of Women with Higher 
Education, the Foundation of the Graduates of the Er-
enköy High School for Girls, and the Soroptimist In-
ternational, a worldwide volunteer service organization 
for business and professional women who work in par-
ticular to improve the lives of women and girls.30 
In the obituary written after her death, Hasan Der-
man underlined the special place of her pharmacy in 
Fatma Belkis Derman’s life with the following words: 
For Belkis, her pharmacy was always more than just 
a purpose and target; it was the greatest joy, a unique 
ambition and desire of her life until her last breath.31 
Fatma Belkis Derman was laid to rest in the Zincirli-
kuyu Cemetery in Istanbul. She was survived by her 
only son, Mehmet Uğur Derman (1939-1994), who was 
a professor of oncology at the Cerrahpaşa Faculty of 
Medicine in Istanbul at the time he and his wife were 
killed in a road traffi  c accident.32
Derman’s historical importance
Fatma Belkis Derman is a monumental fi gure in the 
history of Turkish pharmacy, paving the way for Turk-
ish women to pursue pharmaceutical careers. Being a 
woman of strength and courage, she became the fi rst 
female pharmacist in Turkey to set up a community 
pharmacy, operate a laboratory, receive a license for 
pharmaceutical products, and become a commercial 
partner of a drug warehouse, as well as a member of a 
pharmaceutical society. Despite various obstacles and 
even disdain among the locals of her time, she made 
women pharmacists visible and respectable in Turkey.33
Moreover, she served as a role model for later wom-
en pharmacists to rise in her country, together with 
many Middle Eastern countries. Th is should possibly 
include Najah al-Saati (1915-2016), who became the 
fi rst female pharmacist in Syria, and presumably the 
Figure 4. Stationary of Fatma Belkis Derman’s İstanbul 
Eczanesi (the Istanbul Pharmacy) with its label including 
a pharmaceutical logo together with caduceus and the in-
scription of Belkis Derman’s name, ca. 1941. (Source: Mert 
Sandalcı Collection)
Th e proprietary medicines Derman produced in her 
pharmacy were Kinol, Vinokinyum and Comprimé 
Sulfaseptin, of which only the last one was patented in 
her name.24, 25 Although she additionally became man-
ager of the Istanbul Pharmaceutical Laboratory on 16 
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whole Arabic world, after graduating from the Damas-
cus Faculty of Medicine in 1949.34
Fatma Belkis Derman was also followed by many 
of her colleagues as the fi rst females in diff erent fi elds 
of pharmacy in Turkey, spanning from academia to the 
drug industry (Table 1).35-41 Among them, Hayriye 
Amâl (1912-2005) is of great signifi cance as the fi rst fe-
male pharmacist to receive a PhD in pharmacy (1942), 
becoming a full professor (1950) and serving as dean of 
the Faculty of Pharmacy (1969-1970). Following in Fat-
ma Belkis Derman’s footsteps, the number of female 
pharmacists had reached 20,045 in Turkey in 2017 – 
constituting 56.4% of the 35,537 pharmacists in the 
country – indicating a slight but continuous increase in 
recent years.42
Conclusion
Fatma Belkis Derman deserves to be remembered with 
great admiration and respect for achieving a milestone 
in the history of Turkish pharmacy, and as a devoted 
woman of many fi rsts in her relatively short life. She 
will continue to serve as an inspiration for girls, not 
only in Turkey but also in other countries around the 
world, where they are deprived of the opportunity of an 
Year Achievement as the fi rst Name of female pharmacist Graduation place Year
1924 pharmacy student Ayşe Saadet Hanım (?–?) not graduated -
1930 pharmacy graduate and com-
munity pharmacist
Fatma Belkıs Derman (1906–
1958)
Istanbul Univ. 1930
1930 pharmacy graduate and teach-
ing assistant
Fatma Bedriye Siren (1910–
2007)
Istanbul Univ. 1930
1930 pharmacy graduate and teach-
ing assistant
Ayşe Semiha Erçin (1907–?) Istanbul Univ. 1930
1935 pharmacy graduate with the 
fi rst rank
Semahat Hanım (?–?) Istanbul Univ. 1935
1942 holder of doctorate degree in 
pharmacy
Hayriye Amâl (1912–2005) Istanbul Univ. 1936
1942 director of a drug warehouse Leman Kazuk Başkur (1918–
2012)
Istanbul Univ. 1940
1943 owner of a pharmaceutical 
laboratory
Leman Kazuk Başkur (1918–
2012)
Istanbul Univ. 1940
1944 associate professor Hayriye Amâl (1912–2005) Istanbul Univ. 1936
1950 full professor Hayriye Amâl (1912–2005) Istanbul Univ. 1936
1957 deputy member Emine Piraye Levent (1915–
1992)
Istanbul Univ. 1936
1959 director of pharmaceutical 
factory
Güzin Tamaç-Poff et (1926) Univ. of Bern 1953
1969 dean of a Faculty of Pharmacy Hayriye Amâl (1912–2005) Istanbul Univ. 1936
1980 president of a pharmacy cham-
ber
Nermin Usal (1929–2015) AITIA EYO* 1975
1988 vice rector Nuriye Aslı Özer (1942) Ankara Univ. 1965
1991 minister of state Güler İleri (1948) AITIA EYO* 1974
1992 member of Académie nationale 
de pharmacie**
Afi fe Mat (1953) Istanbul Univ. 1976
1999 recipient of the TÜBITAK*** 
service award
Asuman Baytop (1920–2015) Istanbul Univ. 1943
2015 president of the EUFEPS**** Erem Bilensoy (1971) Hacettepe Univ. 1992
* Ankara İktisadi ve Ticari İlimler Akademisi Eczacılık Yüksek Okulu (Th e Ankara Academy of Economics and 
Commercial Sciences School of Pharmacy), Ankara. ** Th e French National Academy of Pharmacy, Paris. *** Th e 
Scientifi c and Technological Research Council of Turkey, Ankara. **** Th e European Federation for Pharmaceu-
tical Sciences, Stockholm.
Table 1. Th e fi rst female pharmacists in diff erent fi elds of Turkish pharmacy (1924–2015)35-41
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education – a fundamental human right that should 
never be relinquished. 
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Reviewed by Stuart Anderson
Just two years later, in 1785, the entire Act was re-
pealed only to be replaced by a new one. Th is imposed 
the same sort of obligations on sellers, but now exempt-
ed from duty certain classes of medicine. Th ese includ-
ed medicines specifi ed in the First and Second Books 
of Rates – lists of import duties imposed on a wide 
range of natural drugs, including roots and barks, and 
chemicals such as alum and white lead. Th ey also in-
cluded ‘entire drugs’, i.e. those that were uncompound-
ed and unmixed, and preparations sold by exempted 
persons, provided that ‘the properties, qualities, virtues 
and effi  cacies’ were ‘known, admitted and approved’ in 
the prevention or treatment of human ailments.
So began 150 years of legal wrangling about the 
meaning of ‘known, admitted and approved’ and other 
phrases in the legislation, the interpretation of which 
invariably fell to the revenue offi  cers. In this book 
Chantal Stebbings traces the history of that wrangling, 
and in the process demonstrates the great benefi t that 
fell to the chemists and druggists in being exempt from 
medicine stamp duty.  Following the test case of Farm-
er vs Glyn-Jones in 1903, chemists and druggists were 
permitted to sell proprietary medicines free of duty 
(provided the formula was disclosed and that the pro-
cess of disclosure was easy) thus giving them a substan-
tial fi nancial advantage over their competitors. One 
consequence of the ruling was a proliferation of books 
of pharmaceutical formulas, supplementing the British 
Pharmacopoeia and British Pharmaceutical Codex, 
amongst others.
In presenting her study Stebbings has two main 
aims; fi rstly, to illustrate broad themes that were of 
great importance to the development of tax law and the 
wider legal order; and secondly, to demonstrate that the 
duty, and the way it was administered, had a profound 
and unforeseen eff ect on the structures and practice of 
professional pharmacy. Th e tax, she argues, was a po-
tent force in the development of the practice of phar-
macy in Great Britain. She seeks to ensure that ‘tax 
takes its place in the intellectual infrastructure of phar-
maceutical history.’ She hopes that it will ‘provide new 
insights and fresh perspectives which might allow new 
connections to be made’, and ‘provide an accessible re-
source for scholars pursuing alternative discourses in 
the fi eld of pharmaceutical history’. Th ese are bold 
claims and deserve close scrutiny.
Th e contents of the book are divided into fi ve chap-
ters. Chapter 1 sets the scene by describing proprietary 
medicines and the fi scal state, exploring the nature of 
quackery, the taxation of proprietary medicines and the 
fi nancial rationale for the tax. Chapter 2 explores the 
medicine stamp duty and the authority of law, covering 
enforcement issues, legislative drafting and revenue 
Taxing medicines is potentially a quick and easy way 
for governments to raises revenue, and it remains a con-
tentious issue. Medicine stamp duty was introduced in 
Great Britain in 1783 and was only abolished in 1941, 
some 158 years later. It was introduced as a source of 
revenue for the government, and was imposed on all 
so-called quack medicines, both patent and proprietary. 
Th is books traces the twists and turns of the tax and its 
implementation as it evolved over many decades.
Th e fi rst Act, in 1783, imposed upon ‘venders and 
sellers of medicines in Great Britain’ the obligation to 
take out an annual licence. But three classes of seller 
were exempt from having a licence; those who had 
served an apprenticeship to a surgeon, apothecary, 
druggist or chemist; those who kept a shop only for the 
sale of drugs and medicines; and surgeons who had 
served in the navy or army. Th e medicines sold had to 
bear a stamp indicating that the duty had been paid.
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practice. Chapter 3 considers the tax and the profession 
of pharmacy, and explores the role of chemists and 
druggists in the legislation, professional reactions to the 
tax, and the impact of the tax concerning professional-
ism.
Chapter 4 investigates the relationship between the 
tax and the integrity of medicines. It explores the dan-
gers of proprietary medicines, regulatory objectives and 
eff ects of the tax, perceptions of quality and safety of 
medicines, and the origins of the government labora-
tory. Finally, Chapter 5 narrates the demise of the tax, 
explores the abuse of revenue practice and the question 
of legality. Ultimately, the Pharmacy and Medicines 
Act of 1941 abolished medicine stamp duty and made 
it compulsory to disclose the names and quantities of 
active ingredients of all non-prescribed medicines for 
human use on the label or container. Th e chapter ends 
by considering whether the tax should be judged as a 
fi scal nonentity or as a revealing paradigm.
An entire book on an apparently minor tax might 
at fi rst seem rather excessive. But Stebbings points out 
that ‘an enduring tax on a specifi c commodity is rare 
in the history of taxation, especially one that remained 
essentially unreformed for the whole of its long life’. Th e 
book is therefore likely to be of considerable interest to 
historians of taxation. For pharmaceutical historians 
the most interesting chapter is likely to be that concern-
ing the tax and the profession of pharmacy. Stebbings 
argues that medicine stamp duty had two positive ef-
fects on the occupational coherence of chemists and 
druggists: it conferred legislative recognition and legit-
imacy on the profession; and it acted as a catalyst for 
unity amongst a disparate occupational group.
However, she shows that the tax failed in its inci-
dental regulatory purpose, and in reality had a negative 
eff ect, in that the stamp was perceived wrongly by users 
to be a guarantee of quality. It did however have a pos-
itive eff ect in encouraging disclosure of the formula. 
But ultimately Stebbings concludes that the most pow-
erful eff ect of the medicine stamp duty on the phar-
macy profession was a negative one. As a tax on a com-
modity, the tax increased the commercial character of 
chemists and druggists, and this proved the most po-
tent obstacle to full professionalization. It reinforced 
the perception of chemists and druggists as traders rath-
er than professionals, it focused attention on the prod-
uct rather than the service, and it helped shape public 
perceptions of pharmacy that linger today.
Th e book is well-written and is logically structured 
and organised. Th e topic has been meticulously re-
searched and the book is extensively and clearly refer-
enced; there can hardly be a single source relating to 
the history of medicine stamp duty that has not made 
an appearance here. In accordance with the Cambridge 
University Press house style notes and references appear 
as footnotes rather than endnotes. Th is book will be an 
essential resource for historians wanting to learn more 
about the taxation of medicines and its impact on the 
profession of pharmacy.
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